NPPA and myeloid sarcoma: The development and progression of numerous diseases affecting the CNS (including MS) are connected to an enzymatic imbalance of the KP and chronic changes in the physiological concentration of certain kynurenine metabolites (Platten et al., 2005; Lim et al., 2010; Mancuso et al., 2015).